Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
Dhammapoj Jeerakornpassawat, Prapaporn Suprasert
Obstet Gynecol Sci. 2020;63(1):55-63.   Published online 2019 Dec 23     DOI: https://doi.org/10.5468/ogs.2020.63.1.55
Citations to this article as recorded by Crossref logo
REKÜRRENTVE/VEYA METASTATIK JINEKOLOJIK TÜMÖRLERDE TEDAVİ ÖNCESİ NÖTROFİL-LENFOSİT ORANI VE TROMBOSİT-LENFOSİT ORANI TERAPÖTİK ETKİYE SAHİP MİDİR?
Ozlem YETMEN DOGAN, Makbule EREN
Kocatepe Tıp Dergisi.2021; 22(2): 125.     CrossRef
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri
Journal of Ovarian Research.2021;[Epub]     CrossRef
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study
Alberto Farolfi, Emanuela Scarpi, Filippo Greco, Alice Bergamini, Lucia Longo, Sandro Pignata, Claudia Casanova, Gennaro Cormio, Alessandra Bologna, Michele Orditura, Laura Zavallone, Laura Attademo, Valentina Gallà, Elisena Franzese, Eva Pigozzi, Vera Lo
Scientific Reports.2020;[Epub]     CrossRef